Guidelines for the management of asthma
Below is a list of links to the most recent guidelines for asthma management. While details may vary, guidelines emphasize an aggressive anti-inflammatory approach, regular physician follow-up, and attention to asthma triggers, all of which are necessary to gain and maintain long-term control of persistent asthma.
Note: These Web sites are external to AstraZeneca. AstraZeneca does not possess editorial control of their content, and no endorsement, expressed or implied, is intended.
Asthma guidelines
The 2007 NHLBI/NAEPP Guidelines at a Glance, the revised guidelines from the National Heart, Lung, and Blood Institute (NHLBI) and the National Asthma Education and Prevention Program (NAEPP) are focused on achieving control. Includes the stepwise approach to treating persistent asthma, as well as information on ongoing monitoring.
The 2007 NHLBI/NAEPP guidelines, Expert Panel Report: Guidelines for the Diagnosis and Management of Asthma. (Update on Selected Topics), was developed in response to the growing numbers of children with asthma. These practical guidelines promote optimal management of pediatric asthma, emphasize the safety and importance of long-term prevention, and address, among other things, important accruing scientific data about inhaled corticosteroid therapy in children.
The Joint Task Force on Practice Parameters, Attaining Optimal Asthma Control: A Practice Parameter. Published in 2005 by a committee representing the American Academy of Allergy, Asthma & Immunology (AAAAI), the American College of Allergy, Asthma, and Immunology (ACAAI), and the Joint Council of Allergy, Asthma, and Immunology (JCAAI), this report builds upon the NAEPP report published in 1991 and provides recommendations in the form of summary statements accompanied by grades of recommendations and levels of evidence.
Related topics
The Allergic Rhinitis and Its Impact on Asthma (ARIA) Workshop Group’s Guideline, Allergic rhinitis and its impact on asthma. Helps providers recognize and manage the contribution of allergic rhinitis on asthma
The AAAAI guideline Allergen Immunotherapy: A Practice Parameter reviews the potential benefits and administration of immunotherapy for children with allergic asthma.
The American College of Chest Physician (ACCP) guideline Chronic Cough Due to Asthma: ACCP Evidence-based Clinical Practice Guidelines outlines the diagnosis and management of patients with cough-variant asthma.
The ACCP/ACAAI guideline Device Selection and outcomes of Aerosol Therapy: Evidence-based Guidelines details clinicians on the appropriate selection of inhaled medication delivery devices for asthmatic patients.
Abbreviations
- AAAAI—American Academy of Allergy, Asthma & Immunology
- AAP—American Academy of Pediatrics
- ARIA—Allergic Rhinitis and its Impact on Asthma
- ACCP—American College of Chest Physicians
- ACAAI—American College of Allergy, Asthma & Immunology
- JCAAI—Joint Council of Allergy, Asthma and Immunology
- NAEPP—National Asthma Education and Prevention Program
- NHLBI—National Heart, Lung, and Blood Institute
- NIH—National Institutes of Health
Some files on this page require Adobe
® Reader
® to be installed. If you do not have
Adobe Reader on your computer, you can
download it here.